Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.

Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.

Item
http://www.wikidata.org/entity/Q35236076
Everolimus and Malignancy after Solid Organ Transplantation: A Clinical UpdateTAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia.m-TOR inhibitors and their potential role in haematological malignancies.New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes.Emerging drugs and combinations to treat multiple myeloma.VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim.Bone-Targeted Therapies in Cancer-Induced Bone Disease.PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise.The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma.Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report.
P2860

Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.

Item
http://www.wikidata.org/entity/Q35236076
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@ast
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@en
type
label
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@ast
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@en
prefLabel
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@ast
Activity of everolimus (RAD001 ...... iple myeloma: a phase I study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Activity of everolimus (RAD001 ...... tiple myeloma: a phase I study
@en
P2093
P2860
P304
P31
P356
10.3324/HAEMATOL.2014.116269
P433
P478
P50
P577
P5875
P698
P932